SN6
SHORT NOTE
5M
Define teratoma. Classify teratomas and describe the ovarian mature cystic teratoma.
Definition
A teratoma is a tumour arising from totipotent germ cells, containing tissue derived from all three germ layers — ectoderm, mesoderm and endoderm.
- Sites — gonads (ovary and testis), and midline extragonadal sites where germ cells arrest during migration: sacrococcygeal region, mediastinum, retroperitoneum, pineal
- Sacrococcygeal teratoma is the commonest tumour of the newborn, arising from remnants of the primitive streak
Classification
| Type | Features | Behaviour |
|---|---|---|
| Mature (benign) | Well-differentiated adult tissue — skin, hair, teeth, cartilage, thyroid, neural tissue | Benign in the ovary; the commonest ovarian tumour in young women |
| Immature | Contains embryonic or fetal tissue, especially primitive neuroepithelium | Malignant; graded by the amount of immature tissue |
| Monodermal (specialised) | Composed of one tissue — struma ovarii (thyroid tissue), carcinoid | Struma ovarii may cause thyrotoxicosis |
| Teratoma with malignant transformation | A somatic malignancy arising within a mature teratoma — usually squamous cell carcinoma | Malignant |
CLINICAL PEARL
The same histology behaves entirely differently in the two sexes. A mature teratoma of the ovary is benign, whereas a teratoma of the adult testis is malignant whatever its degree of maturity, and metastasises. In the prepubertal testis, however, mature teratoma is benign. Age and site therefore matter as much as the histology.
Ovarian Mature Cystic Teratoma (dermoid CYST)
- The commonest ovarian germ cell tumour; typically in women of reproductive age; bilateral in 10–15%
- Naked eye — a unilocular cyst filled with sebaceous material and hair, with a rokitansky protuberance from which teeth and bone project
- Microscopy — skin with adnexa, cartilage, bone, thyroid, respiratory and gastrointestinal epithelium, neural tissue
- Complications — torsion (the commonest), rupture with granulomatous peritonitis, infection, and malignant transformation in about 1%
Testicular Germ Cell Tumours in Context
| Tumour | Markers | Notes |
|---|---|---|
| Seminoma | HCG may be mildly raised; AFP is never raised | Radiosensitive; excellent prognosis |
| Yolk sac tumour | AFP | Commonest testicular tumour in children |
| Choriocarcinoma | HCG markedly raised | Highly aggressive; haematogenous spread |
| Embryonal carcinoma | AFP and hCG variable | Aggressive |
| Teratoma | AFP or hCG may be raised | Malignant in the adult testis |
- A raised AFP means the tumour is not a pure seminoma, however it looks under the microscope — the marker overrides the histology and changes treatment
Applied Aspects
- Testicular tumours are among the most curable cancers, with over 90% cure even with metastases, because of their exquisite sensitivity to platinum-based chemotherapy
- Markers are measured before and after orchidectomy, and their rate of fall guides further treatment
- Sperm banking must be offered before chemotherapy
- Ovarian dermoid cysts are usually managed by cystectomy, preserving ovarian tissue and fertility in young women
- "Growing teratoma syndrome" — a mass enlarges during chemotherapy while markers fall, because chemotherapy kills the malignant elements and leaves mature teratoma behind; it requires surgical excision, not more chemotherapy
All questions in Neoplasia
- Q1Define neoplasia. Describe the nomenclature of tumours and differentiate benign from malignant tumours. Add a note on anaplasia. ★
- Q2Describe the molecular basis of cancer. Discuss oncogenes, tumour suppressor genes and DNA repair genes with examples. ★
- Q3Classify carcinogenic agents. Describe chemical, radiation and viral carcinogenesis with examples. ★
- Q4Describe the routes of spread of malignant tumours. Explain the metastatic cascade and the factors determining the site of metastasis. ★
- Q5Describe the laboratory methods used in the diagnosis of cancer. Explain grading and staging and add a note on paraneoplastic syndromes. ★
- SN1Define dysplasia and carcinoma in situ. Describe their features and significance. ★
- SN2Define oncogenes. Describe the mechanisms of their activation with examples. ★
- SN3Describe the structure, function and significance of the p53 gene. ★
- SN4Describe the important tumour markers with their uses and limitations. ★
- SN5Describe tumour angiogenesis with its regulation and clinical significance. ★
- SN6Define teratoma. Classify teratomas and describe the ovarian mature cystic teratoma.
- SN7Describe the paraneoplastic syndromes with their mechanisms and associations. ★